Novel drug candidates for treating esophageal carcinoma: A study on differentially expressed genes, using connectivity mapping and molecular docking

Patients with esophageal carcinoma (ESCA) have a poor prognosis and high mortality rate. Although standard therapies have had effect, there is an urgent requirement to develop novel options, as increasing drug tolerance has been identified in clinical practice. In the present study, differentially e...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Ting, Xie, Jia-Yi, Sun, Qi, Mo, Wei-Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254996/
https://www.ncbi.nlm.nih.gov/pubmed/30387840
http://dx.doi.org/10.3892/ijo.2018.4618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254996/
https://www.ncbi.nlm.nih.gov/pubmed/30387840
http://dx.doi.org/10.3892/ijo.2018.4618

Ejemplares similares